Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Blocklisting - Interim Review

14 Mar 2011 12:38

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically.

To: The FSA Date: 14 March 2011 Name of applicant: Charles Taylor Consulting plc Name of scheme: Sharesave and Executive Schemes Period of return: From: 24 July 2010 To: 14 March 2011

Balance under scheme from previous 1,459,444 Ordinary 1p (342,796 return:

Sharesave / 1,116,648 Executive) The amount by which the block scheme None has been increased, if the scheme has been increased since the date of the last return: Number of securities issued/allotted None under scheme during period:

Balance under scheme not yet issued/ 1,459,444 Ordinary 1p (342,796 allotted at end of period

Sharesave / 1,116,648 Executive)

Number and class of securities 29,158,141 Ordinary 1p shares,10 originally listed and the date of October 1996

admission Total number of securities in issue at 40,344,664

the end of the period Name of contact: Robert Bird Address of contact: Standard House, 12-13 Essex Street, London, WC2R 3AA Telephone number of 020 3320 2204 contact: SIGNED BY ______________________________________________

Director/company secretary/suitably experienced employee/duly authorised officer,

for and on behalf of

Charles Taylor Consulting plc

Name of applicant

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

vendor

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.